Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 867, pseudogene (RNU6-867P) is a genomic locus annotated as a pseudogene of the U6 small nuclear RNA (snRNA) gene family, specifically the 867th such annotated pseudogene in the human genome[4][5]. U6 snRNA is an essential component of the spliceosome, a ribonucleoprotein machinery responsible for pre-mRNA splicing in eukaryotic nuclei[1][3]. Pseudogenes such as RNU6-867P are DNA sequences similar to functional genes but generally considered non-functional due to the accumulation of disabling mutations (such as insertions, deletions, or lack of regulatory elements). Like many other U6-related pseudogenes, RNU6-867P may be transcriptionally silent, or in rare cases, transcribed into non-coding RNA without a defined, sequence-encoded function[4][5]. Some pseudogenes have been shown to act as sources of regulatory small RNAs or competing endogenous RNAs in other contexts, but there is no specific evidence of a functional or therapeutic role for RNU6-867P[2]. It is not considered a therapeutic target, and there are no drugs, clinical biomarkers, or documented safety considerations associated with this sequence. Key points: - The sequence is a non-coding RNA pseudogene, not a protein-coding gene, receptor, enzyme, or transporter[4][5]. - It is not known to have direct biological or disease relevance and is not targeted by drugs. - Standardized databases (e.g., NCBI, Ensembl) catalog it strictly as a pseudogene[4]. - Some pseudogenes can have regulatory effects, but no such effect has been ascribed to RNU6-867P in the literature[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 867, pseudogene (RNU6-867P).